Share
PrintTest Details
Turnaround TimeUse
The Labcorp Plasma Complete test is a next-generation sequencing based laboratory developed test for the detection of genomic sequence mutation in 521 clinically actionable or relevant genes including amplifications in 12 genes, translocations in 12 genes and microsatellite instability (MSI) from plasma-derived cell-free DNA (cfDNA). The test is intended to be used by qualified healthcare professional in accordance with professional oncology guidelines for patients already diagnosed with advanced stage or metastatic solid tumors. Test results are not prescriptive for the use of any specific therapeutic product.
Special Instructions
Specimens must be submitted using the Liquid Biopsy Specimen Kit and shipped directly to PGDx lab location using the shipping label provided in the kit.
Methodology
Next-generation sequencing
Specimen Requirements
Information on collection, storage, and volume
Specimen
Blood
Volume
2 tubes of 10 mL each
Minimum Volume
2 tubes of 10 mL each
Container
Only the Liquid Biopsy Specimen Kit (PeopleSoft No. 137408) can be used for collection.
Storage Instructions
Maintain at room temperature after collection and during shipping.
Causes for Rejection
Samples not collected and submitted in Streck tubes; specimens submitted in expired or incorrect blood tubes; quantity not sufficient for analysis; specimens received more than seven days from collection; frozen specimens
Collection
Collect 10 mL of whole blood into each of 2 Streck BCT tubes supplied in the Liquid Biopsy Specimen Kit.
